GlassScriptPhysician profile
Daniel L Margolin
NPI 1386627149
$548.97
in general payments reported to CMS, 2019-2025
14 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $76.99 · 2023: $104 · 2024: $103 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $471.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $142.54 | 2025 | Citrefix, Augment Injectable |
| Treace Medical Concepts, INC. | $61.47 | 2022-2025 | |
| Organogenesis INC. | $49.13 | 2023 | Puraply |
| Integra Lifesciences Corporation | $48.53 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medshape, INC. | $38.64 | 2023 | Dynanail |
| International Rehabilitative Sciences, INC | $31.61 | 2024 | Rs 4i Plus Sequential Stimulator |
| Highridge Medical LLC | $30.11 | 2024 | Biomet Ebi Bone Healing System |
| Hartmann USA, INC. | $25.88 | 2025 | Zetuvit Plus 10x10 P10 |
| Convatec INC. | $25.78 | 2024 | |
| Orthofix Medical, INC. | $25.15 | 2025 | Physio-Stim |
| Acera Surgical, INC. | $20.20 | 2025 | Restrata Wound Matrix |
| Zimvie INC. | $18.77 | 2022 | |
| Smith+Nephew, INC. | $15.77 | 2023 | Regranex, Collagenase Santyl |
| Musculoskeletal Transplant Foundation INC. | $15.39 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Margolin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.